MR1 and non-small cell lung carcinoma: Subsequently, the IHC tests were performed to detect the expression of MR‐1 in 40 NSCLC patients and their tissue arrays of corresponding metastatic cancer (Figure3A) through TMA (LUM961), and found that MR‐1 was highly expressed in metastatic cancer tissues.